Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
201-500
employees, estimated range
Backers
2
Inveready, Sodena
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
PROSION Therapeutics is a drug development company that utilises cutting-edge technology to unlock so far undruggable targets and address…
RayzeBioVenture round $167.9M · 4 yr ago • Founded 2020 • 1001-5000 employees
What We Do We are focused on creating precision radiopharmaceutical therapies (RPTs) that transform people’s lives.
Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological…
Variant BioVenture round $105M · 4 yr ago • Founded 2018 • 201-500 employees
Variant Bio is developing life-saving therapies by studying the genes of people with exceptional health-related traits.
Draupnir Bio is developing new innovative therapies for patients.
Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key…

Overview

"We are committed to creating the future of oncology by developing innovative therapies inducing autophagy to address unmet medical needs".

News

Press release PRNewswire 2 years ago
AbilityPharma Announces € 7 Million Financing Round to Advance Development of its Clinical Phase 2b Autophagy Inducer ABTL0812 in Metastatic Pancreatic Cancer
/PRNewswire/ -- The Catalan biopharmaceutical company Ability Pharmaceuticals, SA (AbilityPharma), focused on the development of innovative oral...
Read more
Report